If you or someone you know struggles with lichen planus (LP)—a chronic, often stubborn inflammatory condition—you’re likely familiar with the frustration of recurring symptoms and limited treatment success. Among its various forms, oral lichen planus (OLP) is particularly debilitating, affecting the mucous membranes of the mouth, causing discomfort, erosion, and even difficulty eating. But recent clinical research highlights a promising solution: the 308-nm excimer laser. This targeted therapy is redefining how we approach LP treatment, offering safety, efficacy, and hope for patients unresponsive to conventional methods.

Why Traditional Treatments Fall Short for Lichen Planus

Lichen planus, including OLP, is characterized by chronic inflammation, lymphocytic infiltration in lesions, and a tendency to relapse. Traditional treatments like narrow-spectrum UVB phototherapy have proven effective for skin LP, but their bulky design makes them impractical for treating oral lesions. Many patients also fail to respond to standard therapies, leaving them with persistent symptoms such as painful erosions, white patches, and inflammation that significantly impact quality of life (Liu et al., 2017; Trehan & Taylor, 2004).

How 308-nm Excimer Laser Works Its Magic

The 308-nm excimer laser stands out for its precision and targeted mechanism of action. Unlike broad-spectrum therapies, it delivers focused ultraviolet radiation directly to affected areas, minimizing exposure to healthy tissue. The key to its success lies in its ability to induce apoptosis (cell death) in T lymphocytes—immune cells that play a central role in the inflammatory cascade of LP. By targeting these cells, the laser reduces inflammation at the source, alleviating symptoms and promoting lesion healing (Liu et al., 2017; Köllner et al., 2003).

For OLP specifically, the laser’s compact fiberoptic handpiece allows clinicians to treat hard-to-reach oral lesions with unparalleled accuracy, a major advantage over bulky traditional UVB devices (Trehan & Taylor, 2004). This precision not only enhances efficacy but also reduces the risk of side effects, making it a safe option for long-term use.

Clinical Evidence: Efficacy Backed by Research

Numerous studies have validated the 308-nm excimer laser’s effectiveness for both OLP and childhood LP, a population where treatment options are often limited.

In a study of six OLP patients, Liu et al. (2017) reported satisfactory outcomes: 2 patients achieved complete clinical recovery (erosions and white spots fully resolved), 3 experienced partial remission (erosions healed, lesions reduced by over 50%), and only 1 had minimal improvement. Notably, side effects were mild—just one patient reported transient pain that resolved spontaneously—confirming the therapy’s safety profile.

For pediatric patients, Mzoughi et al. (2024) documented successful treatment of an unusual presentation of childhood LP using the 308-nm excimer laser. The patient’s erythematous papules with scaling (a rare manifestation in children) cleared completely after treatment, highlighting the laser’s versatility across age groups and LP variants.

Even in patients unresponsive to conventional therapies, the laser delivers impressive results. Trehan & Taylor (2004) studied nine symptomatic OLP patients who had failed standard treatments. After just seven weekly sessions of low-dose 308-nm laser therapy, 5 patients showed excellent improvement (over 75% reduction in lesions), 2 had fair responses, and only 1 (with concurrent chronic hepatitis C) had poor results. Remission times for responders ranged from 2 to 17 months, demonstrating long-lasting benefits (Trehan & Taylor, 2004).

Early preliminary research also supports these findings: Köllner et al. (2003) treated eight OLP patients with the 308-nm UVB excimer laser, achieving clinical improvement in six and complete remission in two. While one patient experienced a recurrence after four weeks, the results underscored the laser’s potential as a valuable addition to the LP treatment arsenal.

Why 308-nm Excimer Laser Is a Preferred Choice

Beyond its efficacy, the 308-nm excimer laser offers several key advantages:

• Safety: Minimal side effects (mostly mild, transient pain) and no systemic toxicity, making it suitable for long-term use.
• Precision: Targeted delivery avoids healthy tissue damage, critical for delicate oral mucosa.
• Versatility: Effective for both OLP and childhood LP, addressing unmet needs in diverse patient groups.
• Accessibility: Compact design and fiberoptic handpiece enable treatment of oral lesions that were previously untreatable with bulkier devices.

Final Thoughts: A New Era for Lichen Planus Treatment

For patients living with the burden of lichen planus—especially oral lichen planus—the 308-nm excimer laser represents a breakthrough. Backed by clinical research (Liu et al., 2017; Mzoughi et al., 2024; Trehan & Taylor, 2004; Köllner et al., 2003), this therapy offers a safe, targeted, and effective alternative to conventional treatments. Whether you’re a patient seeking relief or a healthcare provider looking to expand treatment options, the 308-nm excimer laser is a testament to how innovative technology can transform care for chronic inflammatory conditions.

If you’re struggling with treatment-resistant LP, talk to your dermatologist or oral medicine specialist about whether 308-nm excimer laser therapy is right for you. The future of LP treatment is brighter than ever, and this laser therapy is leading the way.

References

1. Liu, W. B., Sun, L. W., Yang, H., & Wang, Y. F. (2017). Treatment of oral lichen planus using 308-nm excimer laser. Dermatol Ther, 30(5), 12510. https://doi.org/10.1111/dth.12510
2. Mzoughi, D., Rabhi, F., Slimane, M. B., Mallek, I., Jaber, K., & Dhaoui, M. R. (2024). An unusual presentation of childhood lichen planus successfully treated with 308-nm excimer laser. J Cosmet Dermatol, 23(12), 4371-4373. https://doi.org/10.1111/jocd.16522
3. Trehan, M., & Taylor, C. R. (2004). Low-dose excimer 308-nm laser for the treatment of oral lichen planus. Arch Dermatol, 140(4), 415-420. https://doi.org/10.1001/archderm.140.4.415
4. Köllner, K., Wimmershoff, M., Landthaler, M., & Hohenleutner, U. (2003). Treatment of oral lichen planus with the 308-nm UVB excimer laser–early preliminary results in eight patients. Lasers Surg Med, 33(3), 158-160. https://doi.org/10.1002/lsm.10202